These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 12727472)
21. Direct evidence for in vivo induction of CD8+ cytotoxic T cells directed to donor MHC class I peptides following mouse allotransplantation. Popov IA; Fedoseyeva EV; Orr PL; Garovoy MR; Benichou G Transplantation; 1995 Dec; 60(12):1621-4. PubMed ID: 8545902 [TBL] [Abstract][Full Text] [Related]
22. Differential regulation of rejection of small intestinal and skin allografts in rats by injection of antibodies to ICAM-1 or the integrins alpha 4, alpha L, or beta 2. Gorczynski RM; Fu XM; Issekutz T; Cohen Z Cell Immunol; 1998 Feb; 184(1):74-82. PubMed ID: 9626338 [TBL] [Abstract][Full Text] [Related]
23. Natural killer T cell facilitated engraftment of rat skin but not islet xenografts in mice. Gordon EJ; Kelkar V Xenotransplantation; 2009; 16(3):135-44. PubMed ID: 19566653 [TBL] [Abstract][Full Text] [Related]
24. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection. He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771 [TBL] [Abstract][Full Text] [Related]
25. Oral and portal venous tolerance in the interferon-gamma knockout (GKO) mouse. Margenthaler JA; Kataoka M; Flye WM J Surg Res; 2004 Jun; 119(2):107-12. PubMed ID: 15145690 [TBL] [Abstract][Full Text] [Related]
26. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion. Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116 [TBL] [Abstract][Full Text] [Related]
27. Gamma delta TCR+ hybridomas derived from mice preimmunized via the portal vein adoptively transfer increased skin allograft survival in vivo. Gorczynski RM; Cohen Z; Leung Y; Chen Z J Immunol; 1996 Jul; 157(2):574-81. PubMed ID: 8752904 [TBL] [Abstract][Full Text] [Related]
28. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts. Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003 [TBL] [Abstract][Full Text] [Related]
29. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model. Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433 [TBL] [Abstract][Full Text] [Related]
30. CD8 T cell of donor splenocyte mixed with bone marrow cells is more effective than CD4 T cell for induction of donor-specific tolerance in sublethally irradiated mice. Yoshida A; Narumi S; Hashimoto N; Itabashi Y; Hakamada K; Sasaki M Transplant Proc; 2004 Oct; 36(8):2418-22. PubMed ID: 15561266 [TBL] [Abstract][Full Text] [Related]
31. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells. Sugiura K; Kato K; Hashimoto F; Jin T; Amoh Y; Yamamoto Y; Morita H; Okumura K; Ikehara S Immunobiology; 1997 Nov; 197(5):460-77. PubMed ID: 9413746 [TBL] [Abstract][Full Text] [Related]
32. Determination of the functional status of alloreactive T cells by interferon-gamma kinetics. Kwun J; Knechtle SJ; Hu H Transplantation; 2006 Feb; 81(4):590-8. PubMed ID: 16495808 [TBL] [Abstract][Full Text] [Related]
33. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells. Ramos A; Merino R; Merino J Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500 [TBL] [Abstract][Full Text] [Related]
34. Host thymectomy and cyclosporine lead to unstable skin graft tolerance after class I mismatched allogeneic neonatal thymic transplantation in mice. RodrĂguez-Barbosa JI; Haller GW; Zhao G; Sachs DH; Sykes M Transpl Immunol; 2005 Oct; 15(1):25-33. PubMed ID: 16223670 [TBL] [Abstract][Full Text] [Related]
35. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol. Siemionow MZ; Izycki DM; Zielinski M Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512 [TBL] [Abstract][Full Text] [Related]
36. CD4+ T cells determine the ability of spleen cells from F1 hybrid mice to induce neonatal tolerance to alloantigens and autoimmunity in parental mice. González M; Schurmans S; Ramos A; Merino R; Lambert PH; Merino J Eur J Immunol; 1995 Jun; 25(6):1760-4. PubMed ID: 7615004 [TBL] [Abstract][Full Text] [Related]
37. Targeted gene disruption of the heat shock protein 72 gene (hsp70.1) in the donor tissue is associated with a prolonged rejection-free survival in the murine skin allograft model. Oh KH; Kim JY; Kim D; Lee EM; Oh HY; Seo JS; Han JS; Kim S; Lee JS; Ahn C Transpl Immunol; 2004 Dec; 13(4):273-81. PubMed ID: 15589740 [TBL] [Abstract][Full Text] [Related]
38. Enhancement of thyroid allograft survival following organ culture: II. Induction of recipient peripheral tolerance. Hullett DA; Sollinger HW Hum Immunol; 1997 Feb; 52(2):127-37. PubMed ID: 9077561 [TBL] [Abstract][Full Text] [Related]
39. Induction of operational tolerance and generation of regulatory cells after intratracheal delivery of alloantigen combined with nondepleting anti-CD4 monoclonal antibody. Aramaki O; Shirasugi N; Akiyama Y; Takayama T; Shimazu M; Kitajima M; Ikeda Y; Niimi M Transplantation; 2003 Nov; 76(9):1305-14. PubMed ID: 14627908 [TBL] [Abstract][Full Text] [Related]
40. Infusion of donor hepatic non-parenchymal cells prolongs survival of skin allografts in mice: role of microchimerism and IL-4. Ding XM; Xue WJ; Ji ZZ; Tian PX Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):34-7. PubMed ID: 17287163 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]